Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Raphael Pharmaceutical Inc.
- Security class
- Common Stock
- Shares / value
- 3,983,701
- Estimated value
- $1,991,851
- Report date
- 02 Mar 2025
- Price
- $0.5000
- Ownership
- Direct